RBCP - Cost comparison between enoxaparin and new oral anticoagulants dabigatran and rivaroxaban in venous thromboembolism prophylaxis
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons | The BMJ
Recommendations for Switching to and From Rivaroxaban 9 | Download Table
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials -
Cureus | Clinical Outcomes and Costs of Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Inpatients: A Cross-Sectional Study
Treatment Considerations | XARELTO® (rivaroxaban) HCP
Guidance on Converting Between Anticoagulants
Guidance on converting between anticoagulants
Antithrombotic Management of Venous Thromboembolism: JACC Focus Seminar - ScienceDirect
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
Care Transitions in Anticoagulation Management for Patients With Atrial Fibrillation: An Emphasis on Safety | Ochsner Journal
![PDF] Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c3bd71fdf61b8f8bdc9321c5d380254016ae03ea/20-Table1-1.png "PDF] Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery | Semantic Scholar")
PDF] Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery | Semantic Scholar
Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week - ScienceDirect
Transition of Anticoagulants 2016
How to switch from rivaroxaban to LMWH? | Download Scientific Diagram
Aspirin and an oral anticoagulant – can they be used together? - NPS MedicineWise
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial - The Lancet
Transition of Anticoagulants 2014
Safety Profile - DVT & PE Initial Treatment | XARELTO® (rivaroxaban) HCP
Time for a change? Switching anticoagulants in patients with AF or VTE | Thrombosis Adviser
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology | Revista Española de Cardiología
Bridging the Gap: How to Transition from the NOACs to Warfarin - PDF Free Download
Transitioning Between Anticoagulants Continuous Infusion Unfractionated Heparin (UFH) SC LMWH or Fondaparinux Rivaroxaban (Xarel
Xarelto® Rivaroxaban The first oral direct factor Xa inhibitor - ppt download
